Comments
Ahmedabad-based animal healthcare player Hester Biosciences Ltd registered a standalone net profit of ₹9.9 crore for Q2 FY19, up 11 per cent from ₹8.85 crore in Q2 FY18. Standalone income from operations stood at ₹42.5 crore (₹38.4 crore).
The Hester board announced an interim dividend of 20 per cent, or ₹2 per equity share on the face value of ₹10 per share. For H1 FY19, its net profit stood at ₹19.6 crore (₹15 crore). “Ninety-six per cent of the sales target and 101 per cent of the profitability target was achieved,” it said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.